Single Pass signs biopsy device distribution deal with Mermaid
Mermaid Medical Group will be the sole distributor of the Single Pass biopsy closure device in the US.
23 January 2024
23 January 2024
Mermaid Medical Group will be the sole distributor of the Single Pass biopsy closure device in the US.
The grant will enable the partners to explore the potential of the technology in tracking the effectiveness of tuberculosis (TB) treatments.
Throughout the study, participants can share their experiences using the prescription medical device, Leva System.
The study was designed to assess the equivalence of visual acuity measurements between Tilak Healthcare’s OdySight app, and traditional eyesight checks.
The system eliminates the need for capital equipment or aspiration and reduces the reliance on thrombolytics.
Adding to prior European Innovation Council investment, the funds will help the start-up’s goal of US market access by 2025.
The 1MED Compliance Pack is designed to facilitate the recertification process for medical device companies as required by the new European MDR.
Fractus' antenna technology allows medical device manufacturers to reach optimal antenna performance within minimal space.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.